Meeting
2021 Genitourinary Cancers Symposium
The BARCODE1 pilot study targeting men with increased genetic risk of developing prostate cancer: Examining the feasibility of a community-based screening program using polygenic risk score to target screening.
Presenter
Jana Kathlyn McHugh, MRCP
Institute of Cancer Research
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Localized Disease
Track
Prostate Cancer - Localized
Sub Track
Prevention, Screening, and Hereditary Cancers
Clinical Trial Registration Number
IRAS257684
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 227)
DOI
10.1200/JCO.2021.39.6_suppl.227
Abstract #
227
Poster Bd #
Online Only
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2022 ASCO Genitourinary Cancers Symposium
The BARCODE1 study in primary care: Early results targeting men with increased genetic risk of developing prostate cancer—Examining the interim data from a community-based screening program using polygenic risk score to target screening.
Speaker: Jana Kathlyn McHugh, MRCP
Videos & Slides
2024 ASCO Annual Meeting
Effect of polygenic risk score for clinically significant prostate cancer in a screening program: The BARCODE 1 study results.
Speaker: Jana Kathlyn McHugh, MD
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
Prostate cancer screening: Have we tipped the seesaw?
Speaker: Matthew David Hobbs, PhD
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
The profile study: Prostate cancer screening in men of Black African and African Caribbean ancestry—Early results.
Speaker: Netty Kinsella